GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (CHIX:CHEMMc) » Definitions » Gross Profit

ChemoMetec AS (CHIX:CHEMMC) Gross Profit : kr367.6 Mil (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is ChemoMetec AS Gross Profit?

ChemoMetec AS's gross profit for the six months ended in Jun. 2024 was kr188.0 Mil. ChemoMetec AS's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was kr367.6 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. ChemoMetec AS's gross profit for the six months ended in Jun. 2024 was kr188.0 Mil. ChemoMetec AS's Revenue for the six months ended in Jun. 2024 was kr208.1 Mil. Therefore, ChemoMetec AS's Gross Margin % for the quarter that ended in Jun. 2024 was 90.34%.

ChemoMetec AS had a gross margin of 90.34% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of ChemoMetec AS was 92.60%. The lowest was 84.83%. And the median was 89.91%.


ChemoMetec AS Gross Profit Historical Data

The historical data trend for ChemoMetec AS's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Gross Profit Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 193.92 253.34 384.25 411.50 367.60

ChemoMetec AS Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 202.56 220.91 190.60 179.63 187.97

Competitive Comparison of ChemoMetec AS's Gross Profit

For the Medical Devices subindustry, ChemoMetec AS's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChemoMetec AS's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Gross Profit distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's Gross Profit falls into.



ChemoMetec AS Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

ChemoMetec AS's Gross Profit for the fiscal year that ended in Jun. 2024 is calculated as

Gross Profit (A: Jun. 2024 )=Revenue - Cost of Goods Sold
=407.87 - 40.275
=367.6

ChemoMetec AS's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=208.073 - 20.107
=188.0

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr367.6 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

ChemoMetec AS's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=188.0 / 208.073
=90.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


ChemoMetec AS  (CHIX:CHEMMc) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ChemoMetec AS had a gross margin of 90.34% for the quarter that ended in Jun. 2024 => Durable competitive advantage


ChemoMetec AS Gross Profit Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


ChemoMetec AS Business Description

Traded in Other Exchanges
Address
Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines